Sionc Pharmaceuticals Private Limited – FDA 483, Nov 15, 2024
An FDA inspection of Sionc Pharmaceuticals Private Limited in Visakhapatnam, India, an Active Pharmaceutical Ingredient and intermediate manufacturer, revealed critical deficiencies in equipment maintenance and qualification. The firm failed to ensure that production equipment, including gaskets and filtration systems, was adequately maintained to prevent contamination of API and intermediates. These issues present a significant risk of chemical, microbiological, and particulate contamination in the manufactured products.
ID · 31ff0711-bde1-4998-b94e-95043ab65cd3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.